Evaluating the transparency of pharmaceutical company disclosure of payments to patient organisations in the UK

Emily Richard, Piotr Ozieranski, Shai Mulinari

Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

Filter

Advancing international comparison of pharmaceutical industry funding of patient advocacy: Focus on Denmark
Mulinari, S., Pashley, D. & Ozieranski, P., 2022 nov. 8, I: Health Policy. 126, 12, s. 1256-1262
Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

Öppen tillgång
Fil
6 Nedladdningar (Pure)
Exposing drug industry funding of UK patient organisations
Ozieranski, P., Richard, E. & Mulinari, S., 2019 maj 23, I: BMJ: British Medical Journal. 365, l1806 .
Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

Öppen tillgång
Fil
93 Nedladdningar (Pure)
Five years of pharmaceutical industry funding of patient organisations in Sweden: cross-sectional study of companies, patient organisations and drugs
Mulinari, S., Vilhelmsson, A. J., Rickard, E. & Ozieranski, P., 2020 juni 24, I: PLoS ONE. e.0235021.
Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

Öppen tillgång
Under-reported relationship: a comparative study of pharmaceutical industry and patient organisation payment disclosures in the UK (2012-2016)
Ozieranski, P., Csanadi, M., Rickard, E. & Mulinari, S., 2020 sep. 20, I: BMJ Open. 10, 9, s. 1-11 10:e037351.
Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

Öppen tillgång

Forskningsoutput